Qi Zhao

Qi Zhao is a seasoned professional in health economics and outcomes research (HEOR) with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Global Value & Access for Oncology at Eisai US since December 2018, Qi has also held the position of Director in the same field. Prior to Eisai, Qi worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as Associate Director of Real World Value & Evidence for Cardiovascular conditions, and at Allergan as Senior Manager of HEOR for Infectious Disease. Early career experiences include roles at Columbia University, where Qi contributed as Lab Manager in the Laboratory for Stem Cells and Tissue Engineering and as a Research Assistant in various epidemiological studies. Qi's academic background includes an MPH in Epidemiology from Columbia University Mailman School of Public Health, an MS in Embryology and Histology from Shandong University, and an M.D. in Clinical Medicine from Shandong First Medical University.